Jeanne de Flandre Hospital, Lille Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2006
NCT00378729
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

Lille Hospital : Jeanne de Flandre Hospital

Active Ingredients

Drugs in Phase 4 Trials (2)

follitropin alfa (Gonal-F) (1 trial)

sitagliptin (januvia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Polycystic Ovary Syndrome (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2